Boehringer Ingelheim Kg & Anor v Swingward Ltd.
The Court of Appeal upheld the High Court's findings that reboxing by parallel importers is necessary due to significant market resistance to stickered products, and that neither co-branding nor de-branding as conducted in these cases caused damage to the reputation or distinctiveness of the claimants' trade marks. The passing off claim was dismissed for lack of evidence of deception. However, the Court found the law unclear regarding the necessity test's application to the form of repackaging and relabelling, and referred these questions to the ECJ for clarification. Notice periods for trade mark owners were set at 15 working days for both reboxed and stickered products.
- Parties
- Appellant/claimant: Boehringer Ingelheim KG; Appellant/claimant: Boehringer Ingelheim Pharma GmbH & Co KG; Appellant/claimant: Boehringer Ingelheim Limited; Appellant/claimant: Glaxo Group Limited; Respondent/claimant: Smithkline Beecham plc; Respondent/claimant: Beecham Group plc; Respondent/claimant: Smithkline and French Laboratories Limited; Appellant/claimant: Eli Lilly and Company; Respondent/defendant: Swingward Limited; Respondent/defendant: Dowelhurst Limited
- Jurisdiction
- England and Wales
- Judgment Date
- 05 March 2004
- Procedural Posture
- Civil Appeal / Court of Appeal Judgment on Appeal From High Court, With Reference to ECJ Pending
- Outcome
- Appeals allowed in part, cross-appeals dismissed in part, reference to ECJ for further questions, judgment on form of reboxing and relabelling deferred.
- Legal Topics
- Trade Marks, Parallel Importation, Repackaging of Pharmaceuticals, Passing Off, Exhaustion of Rights, Free Movement of Goods
Case Brief
Summary, issues, holding and outcome
More case intelligence is available
Unlock the full research layer for this judgment.
Parties
Boehringer Ingelheim KG
Appellant/claimant
Boehringer Ingelheim Pharma GmbH & Co KG
Appellant/claimant
Boehringer Ingelheim Limited
Appellant/claimant
Glaxo Group Limited
Appellant/claimant
Smithkline Beecham plc
Respondent/claimant
Beecham Group plc
Respondent/claimant
Smithkline and French Laboratories Limited
Respondent/claimant
Eli Lilly and Company
Appellant/claimant
Swingward Limited
Respondent/defendant
Dowelhurst Limited
Respondent/defendant
Procedural Posture
Civil Appeal / Court of Appeal Judgment on Appeal From High Court, With Reference to ECJ Pending
Legal Issues
- 1 Whether parallel importers may lawfully rebox, co-brand, or de-brand trade-marked pharmaceuticals for the UK market
- 2 Whether the manner of repackaging or relabelling infringes trade mark rights or constitutes passing off
- 3 Whether the necessity test applies to the form and presentation of repackaged goods
Ratio Decidendi
The Court of Appeal upheld the High Court's findings that reboxing by parallel importers is necessary due to significant market resistance to stickered products, and that neither co-branding nor de-branding as conducted in these cases caused damage to the reputation or distinctiveness of the claimants' trade marks. The passing off claim was dismissed for lack of evidence of deception. However, the Court found the law unclear regarding the necessity test's application to the form of repackaging and relabelling, and referred these questions to the ECJ for clarification. Notice periods for trade mark owners were set at 15 working days for both reboxed and stickered products.
Court Disposition
Appeals allowed in part, cross-appeals dismissed in part, reference to ECJ for further questions, judgment on form of reboxing and relabelling deferred.
Orders
- Cross-appeals on passing off and injunction for notice dismissed.
- Cross-appeal on factual necessity to rebox dismissed.
Full Case Text
Judgment text and source record
Sign in to read
Sign in to read the full judgment text
Sign in to read the full judgment text. Downloads and additional research tools may depend on your plan.
Sign in to read the full judgment